Investigating a blood biomarker for pulmonary arterial hypertension
NOTCH3 ECD as a Serum Biomarker for Pulmonary Arterial Hypertension
This study is looking at a protein in the blood called NOTCH3 ECD to see if it can help doctors understand how severe pulmonary arterial hypertension (PAH) is in patients, which could improve how the condition is diagnosed and treated.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11135322 on NIH RePORTER |
What this research studies
This research focuses on understanding the NOTCH3 extracellular domain (ECD) as a potential serum biomarker for pulmonary arterial hypertension (PAH), a serious and progressive lung condition. The study aims to explore how NOTCH3 ECD levels in the blood correlate with the severity of PAH, which could help in diagnosing and monitoring the disease. Researchers will analyze blood samples to determine the relationship between NOTCH3 ECD and the pathological processes involved in PAH, potentially leading to new clinical applications. The findings could enable better patient management and treatment strategies for those affected by this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pulmonary arterial hypertension.
Not a fit: Patients with other forms of pulmonary hypertension or those without a diagnosis of pulmonary arterial hypertension may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment options for patients with pulmonary arterial hypertension.
How similar studies have performed: Previous research has shown promising results in using biomarkers for various diseases, suggesting potential success for this novel approach in PAH.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Thistlethwaite, Patricia a — University of California, San Diego
- Study coordinator: Thistlethwaite, Patricia a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.